The global sales of attenuated vaccines are projected to soar, with an estimated worth of USD 5,068.2 million in 2024 and anticipated to reach USD 9,693.9 million by 2034. This growth trajectory ...

The first influenza vaccine was a monovalent live-attenuated vaccine, which was used in Russia until recently. In 1940, a second strain of influenza virus was isolated; this was named influenza B ...

Aug. 15, 2024 — A unique influenza vaccine candidate that's inhaled ... vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe and ...

Third quarter 2024 U.S. BRIUMVI net revenue of $83.3 millionRaises full year 2024 U.S. BRIUMVI net revenue target to $300 - $305 ...

Live attenuated influenza vaccine (LAIV) (the nasal spray vaccine). Dr. Bass is a board-certified internist, pediatrician, and a Fellow of the American Academy of Pediatrics and the American College ...

In Wisconsin, 18.2% of La Crosse County residents and 14.7% of Chippewa County residents had received at least one dose of the influenza vaccine this season by Oct. 31, according to the Wisconsin ...